Connor, Clark & Lunn Investment Management (CC&L)’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $987K | Sell |
|
|||||
|
2025
Q4 | $1.14M | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $310K | Sell |
|
|||||
|
2024
Q4 | $2.55M | Sell |
|
|||||
|
2024
Q3 | $2.7M | Buy |
|
|||||
|
2024
Q2 | $1.46M | Sell |
|
|||||
|
2024
Q1 | $1.77M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $249K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $1.2M | Buy |
|
|||||
|
2018
Q3 | $247K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $367K | Sell |
|
|||||
|
2014
Q3 | $564K | Sell |
|
|||||
|
2014
Q2 | $1.14M | Sell |
|
|||||
|
2014
Q1 | $3.67M | Buy |
|
|||||
|
2013
Q4 | $1.31M | Buy |
|
|||||
|
2013
Q3 | $1.01M | Buy |
|
|||||
|
2013
Q2 | $742K | Buy |
|